Globally, medical research data remains scattered and fragmented across geographies, authorities and institutions. This limits the ability of researchers to effectively manage, share and analyze complex clinical, molecular and imaging data.
We build data platforms that help address these challenges, supporting researchers in curing disease and improving quality of life.
The future of health research is dependent on the ability to integrate and analyze complex data from diverse sources.
Indoc Research evolved from the Ontario Cancer Biomarker Network (OCBN), which was established in 2005 with support from the Ontario Institute for Cancer Research and the Ministry of Research and Innovation.
OCBN was given a mandate to support cancer researchers in their search for proteomic and genomic biomarkers. Over time, this role evolved to manage data from many other diseases resulting in expansion of its informatics and data management capabilities. OCBN was rebranded in 2014 to Indoc Research.
In 2016, Indoc transitioned its molecular laboratory operations into a separate entity in order to focus on its informatics operations. In 2021, Indoc formally launched Indoc Research Europe gGmbH to manage operations outside of North America.